Literature DB >> 31192617

Activity-Based Probe for Screening of High-Colibactin Producers from Clinical Samples.

Yuichiro Hirayama1, Yuta Tsunematsu1, Yuko Yoshikawa2, Ryota Tamafune1, Nobuo Matsuzaki1, Yuji Iwashita3, Ippei Ohnishi4, Fumihiko Tanioka4, Michio Sato1, Noriyuki Miyoshi5, Michihiro Mutoh6, Hideki Ishikawa7, Haruhiko Sugimura3, Keiji Wakabayashi8, Kenji Watanabe1.   

Abstract

While high-colibactin-producing Escherichia coli is thought to be associated with colorectal oncogenesis, this study is complicated part due to an inability to isolate colibactin adequately. Here, we created fluorescent probes activated by ClbP, the colibactin-maturing peptidase, to identify high-colibactin-producing strains. Our probe served as a valuable clinical diagnostic tool that allowed simple high-throughput diagnostic screening of clinical samples. Furthermore, the probe also allowed identification of high-colibactin producers that would help advance our understanding of colibactin biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31192617     DOI: 10.1021/acs.orglett.9b01345

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  7 in total

1.  Induction of DNA Damage in Mouse Colorectum by Administration of Colibactin-producing Escherichia coli, Isolated from a Patient With Colorectal Cancer.

Authors:  Takumi Narita; Yuta Tsunematsu; Noriyuki Miyoshi; Masami Komiya; Takahiro Hamoya; Gen Fujii; Yuko Yoshikawa; Michio Sato; Masanobu Kawanishi; Haruhiko Sugimura; Yuji Iwashita; Yukari Totsuka; Masaru Terasaki; Kenji Watanabe; Keiji Wakabayashi; Michihiro Mutoh
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Mother-to-infant transmission of the carcinogenic colibactin-producing bacteria.

Authors:  Yuta Tsunematsu; Koji Hosomi; Jun Kunisawa; Michio Sato; Noriko Shibuya; Emiko Saito; Haruka Murakami; Yuko Yoshikawa; Yuji Iwashita; Noriyuki Miyoshi; Michihiro Mutoh; Hideki Ishikawa; Haruhiko Sugimura; Motohiko Miyachi; Keiji Wakabayashi; Kenji Watanabe
Journal:  BMC Microbiol       Date:  2021-08-24       Impact factor: 3.605

3.  Association of Escherichia coli containing polyketide synthase in the gut microbiota with colorectal neoplasia in Japan.

Authors:  Motoki Iwasaki; Rieko Kanehara; Taiki Yamaji; Ryoko Katagiri; Michihiro Mutoh; Yuta Tsunematsu; Michio Sato; Kenji Watanabe; Koji Hosomi; Yasuo Kakugawa; Hiroaki Ikematsu; Kinichi Hotta; Jun Kunisawa; Keiji Wakabayashi; Takahisa Matsuda
Journal:  Cancer Sci       Date:  2021-11-22       Impact factor: 6.716

Review 4.  The microbiome-product colibactin hits unique cellular targets mediating host-microbe interaction.

Authors:  Walaa K Mousa
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

5.  Genotyping of a gene cluster for production of colibactin and in vitro genotoxicity analysis of Escherichia coli strains obtained from the Japan Collection of Microorganisms.

Authors:  Masanobu Kawanishi; Chiaki Shimohara; Yoshimitsu Oda; Yuuta Hisatomi; Yuta Tsunematsu; Michio Sato; Yuichiro Hirayama; Noriyuki Miyoshi; Yuji Iwashita; Yuko Yoshikawa; Haruhiko Sugimura; Michihiro Mutoh; Hideki Ishikawa; Keiji Wakabayashi; Takashi Yagi; Kenji Watanabe
Journal:  Genes Environ       Date:  2020-03-11

6.  Association between dietary intake and the prevalence of tumourigenic bacteria in the gut microbiota of middle-aged Japanese adults.

Authors:  Daiki Watanabe; Haruka Murakami; Harumi Ohno; Kumpei Tanisawa; Kana Konishi; Yuta Tsunematsu; Michio Sato; Noriyuki Miyoshi; Keiji Wakabayashi; Kenji Watanabe; Motohiko Miyachi
Journal:  Sci Rep       Date:  2020-09-16       Impact factor: 4.379

7.  Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults.

Authors:  Daiki Watanabe; Haruka Murakami; Harumi Ohno; Kumpei Tanisawa; Kana Konishi; Kikue Todoroki-Mori; Yuta Tsunematsu; Michio Sato; Yuji Ogata; Noriyuki Miyoshi; Naoto Kubota; Jun Kunisawa; Keiji Wakabayashi; Tetsuya Kubota; Kenji Watanabe; Motohiko Miyachi
Journal:  BMC Microbiol       Date:  2021-06-28       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.